Cleanse and debride the wound in accordance with normal procedures. Ensure that the skin surrounding the wound is dry. The tube is opened using the piercer cap to break the nozzle seal. To ensure sterility, sanitise the piercer cap before using. Apply a 3mm to 6mm (1/8inch to 1/4inch) layer of keragel® to cover the entire wound surface. Cover with an appropriate secondary dressing if needed.
Rx Only Single Use For Topical Dermatological use only.
Description
DESCRIPTION SECTION
keragel® is a keratin enriched gel category dressing utilizing keratin technology to create and maintain a moist wound environment. It is presented sterile in a tube for ease of application.
INDICATIONS FOR USE
INDICATIONS & USAGE SECTION
keragel® is designed for acute/chronic superficial and partial thickness wounds with dry to medium exudate, such as:
Venous leg ulcers
Arterial ulcers
Diabetic foot ulcers
Pressure ulcers
Skin graft donor sites
Sunburns
First and Second Degree burns
ATTENTION
SPL UNCLASSIFIED SECTION
If the wound is infected, it is advised that you consult with your physician or health care professional.
DIRECTIONS FOR USE
DOSAGE & ADMINISTRATION SECTION
Cleanse and debride the wound in accordance with normal procedures.
Ensure that the skin surrounding the wound is dry.
The tube is opened using the piercer cap to break the nozzle seal. To ensure sterility, sanitise the piercer cap before using.
Apply a 3mm to 6mm (1/8inch to 1/4inch) layer of keragel® to cover the entire wound surface.
Cover with an appropriate secondary dressing if needed.
RECOMMENDED CARE
SPL UNCLASSIFIED SECTION
The wound should be inspected daily or as indicated by a physician. For wounds that appear dry more gel should be applied to the area. Wounds should be cleansed regularly and new gel applied.
Keraplast Research Limited, Gerald St., Lincoln 7674, NZ Medical Device Consultancy, 7 Pinewood Drive, Ashley Heath, Market Drayton, Shropshire TF9 4PA, United Kingdom
keragelT® is a registered trademark of Keraplast Technologies LLC. The product incorporates patented and/or patent pending technologies owned by Keraplast Technologies LLC.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.